Work

A phase Ib trial of Bcl-2 inhibitor obatoclax in combination with carboplatin and etoposide for previously untreated patients with extensive-stage small cell lung cancer (ES-SCLC)

Year: 2009

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2009.27.15_suppl.3576

Authors: A. Chiappori, M. T. Schreeder, M. M. Moezi, J. Stephenson, J. L. Blakely, R. Salgia, Q. S. Chu, S. M. Malik, M. M. Modiano, M. S. Berger

Institutions: Georgetown University, Moffitt Cancer Center, University of Chicago, Cross Cancer Institute

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2246927775

Cites:

Cited by: 11

Related to: 10